Initial research on the human brain concentrated on the suppression of acetylcholinesterase (AChE), one of two cholinesterases that break down acetylcholine, along with butyrylcholinesterase (BuChE), as a therapeutic method for dementia that utilises a cholinergic approach. This evidence concerns the gene BCHE and dementia.